can you take semaglutide if you have breast cancer GLP-1 use linked to lower incidence in large cohort study Weight Loss After Breast Cancer:
Description
Key Takeaways In the first head-to-head trial (SURMOUNT-5, NEJM 2025), tirzepatide produced 20.2% average weight loss vs
By blocking these cravings for high-calorie foods , you guessed it you eat less
Patients who took semaglutide for only four weeks experienced an impressive 2% reduction in body weight, and this weight loss continued throughout the study
NicholsonJHolmesEKinrossJBurcelinRGibsonGJiaWet al
A study from the University of Michigan Medical School in Ann Arbor examined US data between 2020 and 2023
